Centre for Japan Pre-Entry Tuberculosis Screening Quality Assessment, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Department of Epidemiology and Clinical Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Western Pac Surveill Response J. 2022 Mar 28;13(1):1-8. doi: 10.5365/wpsar.2022.13.1.896. eCollection 2022 Jan-Mar.
This report examines the characteristics and treatment outcomes of patients with tuberculosis (TB) who are coinfected with HIV in Japan. Active TB cases newly notified to the Japan Tuberculosis Surveillance system during 2012-2020 were analysed retrospectively, during which 379 HIV-positive TB cases were reported. The proportion of HIV-positive cases among those with known HIV status increased, from 1.9% (62/3328) in 2012 to 3.5% (31/877) in 2020. The proportion of those with unknown HIV testing status was consistently high, at approximately 60%, and the proportion of those who did not undergo HIV testing increased significantly, from 21.6% (4601/21 283) in 2012 to 33.7% (4292/12 739) in 2020. The proportion of foreign-born cases more than tripled, from 14.5% (9/62) in 2012 to 45.2% (14/31) in 2020. The TB treatment success rate was higher among HIV-negative than HIV-positive cases (72.7% [3796/5222] versus 60.3% [88/146]), and among Japan-born than foreign-born HIV-positive patients (65.6% [61/93] versus 50.9% [27/53]), owing largely to the high rate of foreign-born cases transferring to care outside Japan. The increasing proportion of HIV positivity among TB cases tested for HIV in this study requires ongoing monitoring, especially among foreign-born persons. However, because the number of reported cases was small, and there was low completeness of reporting of HIV testing data in the TB surveillance system, these results should be interpreted with caution. Encouraging more complete data collection by training public health nurses who complete TB case interviews and ensuring ongoing monitoring of patients with TB/HIV coinfection are recommended.
本报告探讨了日本合并感染 HIV 的肺结核(TB)患者的特征和治疗结果。对 2012-2020 年期间日本结核病监测系统新报告的活动性 TB 病例进行了回顾性分析,共报告了 379 例 HIV 阳性 TB 病例。已知 HIV 状态的 HIV 阳性病例比例有所增加,从 2012 年的 1.9%(62/3328)上升到 2020 年的 3.5%(31/877)。未知 HIV 检测状态的比例一直较高,约为 60%,未进行 HIV 检测的比例显著增加,从 2012 年的 21.6%(4601/21283)上升到 2020 年的 33.7%(4292/12739)。外国出生病例的比例增加了两倍多,从 2012 年的 14.5%(9/62)上升到 2020 年的 45.2%(14/31)。HIV 阴性病例的 TB 治疗成功率高于 HIV 阳性病例(72.7%[3796/5222]与 60.3%[88/146]),日本出生的 HIV 阳性患者的治疗成功率高于外国出生的患者(65.6%[61/93]与 50.9%[27/53]),主要是由于大量外国出生的病例转移到日本以外的地方接受治疗。在本研究中,HIV 阳性率在接受 HIV 检测的 TB 病例中不断上升,需要持续监测,尤其是在外国出生的人群中。然而,由于报告病例数量较少,且 TB 监测系统中 HIV 检测数据的报告完整性较低,因此应谨慎解释这些结果。建议通过培训完成 TB 病例访谈的公共卫生护士来鼓励更完整的数据收集,并确保对合并感染 TB/HIV 的患者进行持续监测。